Since minimal additional physiological effects are observed in mice with inactivation of Mest, an intervention that represses the function of MEST, or its associated pathway, could be a feasible strategy to mitigate obesity and the inception of T2D. The gene discussed is MEST; the disease is type 2 diabetes mellitus.